364 related articles for article (PubMed ID: 30958259)
1. Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.
Fineran PC
Microbiology (Reading); 2019 Aug; 165(8):834-841. PubMed ID: 30958259
[TBL] [Abstract][Full Text] [Related]
2. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
[TBL] [Abstract][Full Text] [Related]
3. The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.
Smith LM; Jackson SA; Malone LM; Ussher JE; Gardner PP; Fineran PC
Nat Microbiol; 2021 Feb; 6(2):162-172. PubMed ID: 33398095
[TBL] [Abstract][Full Text] [Related]
4. Conquering CRISPR: how phages overcome bacterial adaptive immunity.
Malone LM; Birkholz N; Fineran PC
Curr Opin Biotechnol; 2021 Apr; 68():30-36. PubMed ID: 33113496
[TBL] [Abstract][Full Text] [Related]
5. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.
Richter C; Chang JT; Fineran PC
Viruses; 2012 Oct; 4(10):2291-311. PubMed ID: 23202464
[TBL] [Abstract][Full Text] [Related]
6. How bacteria control the CRISPR-Cas arsenal.
Leon LM; Mendoza SD; Bondy-Denomy J
Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146
[TBL] [Abstract][Full Text] [Related]
7. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
Hwang S; Maxwell KL
CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
[TBL] [Abstract][Full Text] [Related]
8. The interaction of phages and bacteria: the co-evolutionary arms race.
Safari F; Sharifi M; Farajnia S; Akbari B; Karimi Baba Ahmadi M; Negahdaripour M; Ghasemi Y
Crit Rev Biotechnol; 2020 Mar; 40(2):119-137. PubMed ID: 31793351
[TBL] [Abstract][Full Text] [Related]
9. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
Bernheim A
Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of CRISPR-mediated microbial immunity.
Gasiunas G; Sinkunas T; Siksnys V
Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171
[TBL] [Abstract][Full Text] [Related]
11. The Biology of CRISPR-Cas: Backward and Forward.
Hille F; Richter H; Wong SP; Bratovič M; Ressel S; Charpentier E
Cell; 2018 Mar; 172(6):1239-1259. PubMed ID: 29522745
[TBL] [Abstract][Full Text] [Related]
12. Methods for the Analysis and Characterization of Defense Mechanisms Against Horizontal Gene Transfer: CRISPR Systems.
Calvo-Villamañán A; Bernheim A; Bikard D
Methods Mol Biol; 2020; 2075():235-249. PubMed ID: 31584167
[TBL] [Abstract][Full Text] [Related]
13. [Advances in molecular mechanisms of adaptive immunity mediated by type I-E CRISPR/Cas system--A review].
Sun D; Qiu J
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):1-7. PubMed ID: 27305774
[TBL] [Abstract][Full Text] [Related]
14. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
Bradde S; Mora T; Walczak AM
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
[TBL] [Abstract][Full Text] [Related]
15. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci.
Varble A; Meaden S; Barrangou R; Westra ER; Marraffini LA
Nat Microbiol; 2019 Jun; 4(6):956-963. PubMed ID: 30886355
[TBL] [Abstract][Full Text] [Related]
16. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas Systems in Prokaryotes.
Burmistrz M; Pyrć K
Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
Faure G; Makarova KS; Koonin EV
J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
[TBL] [Abstract][Full Text] [Related]
19. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
[TBL] [Abstract][Full Text] [Related]
20. Revenge of the phages: defeating bacterial defences.
Samson JE; Magadán AH; Sabri M; Moineau S
Nat Rev Microbiol; 2013 Oct; 11(10):675-87. PubMed ID: 23979432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
